DOCSLIB.ORG

China's Health Diplomacy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
China's Health Diplomacy Focus Asia Perspective & Analysis September 2021 China’s Health Diplomacy: Taking Forward the Health Silk Road in Southeast Asia Geopolitical competition over Covid-19 vaccines is at its peak. In the absence of a fair and equitable mechanism to coordinate vaccine access, procurement seems to be based either on nationalistic goals or on geopolitical favors. While the extent to which major powers like the US and China are using vaccine diplomacy to create long-term dependencies is yet to be seen, signs of it are already noticeable, for example, in Southeast Asia. China’s health diplomacy there is not new but has always been a major part of their strategic relationship and China’s Health Silk Road. Increasing spotlight on it has, however, invited an increased sense of fervor among the Western countries to also court the region. Engagements are already in full swing, and the ASEAN countries are adopting multilateralism to navigate these complex dynamics. So, this paper first seeks to trace the trajectory of China’s health diplomacy in Southeast Asia. Secondly, we shall see how the Chinese health silk road is opening doors to strategic vaccine diplomacy for China. Introduction are now planning to re-imagine the economy and accelerate growth, distinct diplomatic trends can be Covid-19 has overhauled the global public health seen in the way countries are conducting business order. It has revealed not only the inefficiencies with one other. in the health infrastructure but also the caveats existing in government functioning with regards to Governments are now practicing strategic vaccine formulating an effective response to a pandemic. diplomacy to secure sufficient vaccines for their While the degree of disruption varies, Covid-19 has population. For the vaccine supplying countries, invalidated the notion that the First World is always this has led to a surge in vaccine production and best equipped in times of crisis. Despite having the prejudiced distribution. Covid-19 vaccines are being infrastructure, weathering a pandemic requires a systematically and implicitly instrumentalized for high level of preparation and a robust foundation for political gains and this has huge implications for recovery that cannot be built overnight. As countries the developing world.1 China too is carving a space 1 Focus Asia Perspective & Analysis China’s Health Diplomacy September 2021 for its own global health agenda through its aid and vaccination program. It has made its domestic vaccines “a public good” and distributed them far The Institute for Security and Development Policy is an and wide. independent, non-partisan research and policy organization based in Stockholm dedicated to expanding understanding What helped China increase its distribution of of international affairs. vaccines to the developing world can be traced For enquiries, please contact: [email protected] back to the stance the western countries had taken No parts of this paper may be reproduced without ISDP’s to bolster their vaccination rates. While the latter permission. had overwhelmingly focused on vaccinating their Disclaimer: The opinions expressed in this paper are those of residents first, China positioned itself as a champion the author only and do not necessarily reflect those of ISDP of vaccine distribution, signifying its adherence to or its sponsors. making vaccines a global public good. It also helps their cause that their vaccines—Sinovac, Sinopharm and CanSino Biologics—are more portable, feasible in terms of storage and cheaper than the others. and, more importantly, in regional and global health Having exported on a massive scale, their vaccine governance.4 Covid-19, in this way, has accelerated outreach has been dubbed as vaccine diplomacy, existing geopolitical trends of China’s ascendance aimed primarily to gain influence and favor. The towards attaining leadership in the region. outreach has been in terms of both commercial transactions and donations and more in implicit The Sino-US trade war already has deep economic ways than explicit quid pro quo ways that might ramifications on global supply chains, which undermine China’s soft power.2 are crucial for the region’s interconnected trade- dependent markets. Anticipating a more China- centric world order, commentators debate on how Covid-19 vaccines are the Chinese vaccines could have strings attached being systematically and to them, the South China Sea being the perfect example. So, how will SEA now shape its foreign implicitly instrumentalized policy approach towards China and other major for political gains and this powers like the US? has huge implications for This paper takes a renewed look at the emerging geopolitical realities in the region, a reminder of the the developing world.” non-alignment movement in the past where nations did not engage in isolation but chose not to formally Beijing is also pushing forward its Health Silk Road align with any power bloc. The ASEAN could be (HSR), which, just like the Belt and Road Initiative said to be a forerunner in Asia in this regard— (BRI), leaves room for interpretation but mostly keeping their geopolitical outlook focused on involves cooperating bilaterally and multilaterally in solving transnational issues through consultations, the healthcare sector.3 Such health projects already dialogues, and consensus while maintaining strict exist in the multilateral (ASEAN) and sub-regional non-interference. This, however, does not imply (Mekong region) arrangement, making Southeast major power influence can be obliviated. The paper Asia (SEA) an obvious beneficiary of the HSR will, thus, first trace the trajectory of China’s health due to its proximity to China and their strategic diplomacy from the early years to contemporary partnerships. The HSR adds to China’s already times. In the second part of the paper, we shall see existing health diplomacy by providing a framework how Chinese vaccine diplomacy is rapidly evolving for strengthening its role in medical supply chains now and how other major powers are responding to 2 Focus Asia Perspective & Analysis China’s Health Diplomacy September 2021 it while strengthening their own diplomacy. where cooperation was shaped more by diplomatic technicalities than mere humanitarian goals. Since China’s Early Health Diplomacy Days the end of the 1990s, the Chinese system of health and development has come to be known far and Health diplomacy was defined by Adams and wide. It has been actively pushing for comprehensive Novotny (2007) as the “tools of diplomats and health diplomacy, especially in four sectors—bilateral statecraft [that] can be employed for the dual purposes and multilateral health cooperation, investment in of improving health and relations among nations.”5 health technologies and capital, formal and informal Health-related issues, due to their transboundary health-related discussions, inflow and outflow of nature, are already considered a human security multifarious health assistance.11 Moreover, with challenge, thus requiring international cooperation. increased market-oriented reforms, healthcare has Unlike traditional security threats, which take on taken on a new lease with medical collaborations a zero-sum nature, health diplomacy can be more becoming a source of profit-making. China too is complementary in terms of establishing reciprocal diversifying its foreign aid towards concessional relations in foreign policy.6 medical loans, building medical infrastructure and attaining markets for its pharmaceutical companies In China’s case, health diplomacy has gone through and traditional medicine worldwide.12 several phases, mediated by varying geopolitical concerns. From being a benefiter of health supplies to the World Health Organization (WHO) to China still uses health actually being a consistent partner to African and Latin American countries, China’s history of and developmental health diplomacy touches upon various diplomatic diplomacy as a means to strategies, which has slowly but strategically helped to extend its footprint as a consistent net donor in build strategic, oftentimes global health and development.7 While its foreign what appears to be policy strategies have met several controversies, China still uses health and developmental diplomacy crooked, relationships” as a means to build strategic, oftentimes what appears to be crooked, relationships.8 Now, an important stakeholder in global health governance, China is a crucial source of development Very briefly, China’s initial phase of health diplomacy assistance for health (DAH) and overseas began right after its independence when it was development assistance (ODA), focusing on sharing “leaning towards one side” influenced by Soviet know-how and eradicating transnational infectious Union’s Communist ideology. It was a recipient disease threats.13 While most widely noticed is of the Soviet Union’s health aid and expertise.9 It China’s medical assistance to Africa through the did not take much time to transform from an aid setting up of medical and disease control institutions, recipient to an aid donor, and during the Cold China’s health diplomacy with SEA countries also War period, China organized many missions to goes far back. SEA countries have always been at the “intermediate zones” and dispatched medical the juncture of China’s strategic calculations and supplies to African, Asian, and Latin American economic statecraft. In such scenarios, tapping on countries. It was following the principle of “the poor non-traditional security
Load more

Recommended publications
  • Dentons Flashpoint Daily Global Situation Report
    Dentons Flashpoint Daily Global Situation Report February 8, 2021 Global Situation Update: February 8, 2021 KEY TAKEAWAYS Oxford/AstraZeneca vaccines offers only Nationwide protests Exports from limited protection in Myanmar opposing Britain to EU against mild disease the military coup fell by 68 percent in caused by the swell to tens of January due to South African variant thousands of people Brexit disruptions. of COVID-19. Note: This report is based on sources and information deemed to be true and reliable, but Dentons makes no representations to same. Global Confirmed coronavirus cases globally surpassed 106 million, with deaths at 2.3 million. The rate of new infections and deaths continued to ease. • Across low and middle-income countries, a • A second senior leader of a vast drug median average of 70 percent of those syndicate has been arrested in Thailand, as a surveyed reported a drop in income in the transnational dragnet tightens on the Sam Gor early months of the coronavirus pandemic last group, which police say dominates the $70 year, while 30 percent reported a loss of billion annual Asia-Pacific drug trade. employment and 45 percent said they had missed or reduced meals, according to a study by US universities. Note: This report is based on sources and information deemed to be true and reliable, but Dentons makes no representations to same. Global The number of daily new cases in the US and UK dropped continued to decline, with the UK weekly average dropping below 20,000. France, after recovering from November highs, is edging back up with new outbreaks.
    [Show full text]
  • Boletim Neaape V.05 N.01 - Abr
    ISSN 2594-6935 BOLETIM NEAAPE v.05 n.01 - abr. 2021 BOLETIM NEAAPE ISSN 2594-6935 O Boletim NEAAPE divulga análises sobre o processo decisório de política externa de distintos países, bem como sobre temas que integram as agendas de política exterior. A publicação tem periodicidade quadrimestral e é composta por editorial e textos dirigidos a leitores interessados em ter acesso rápido a informações de qualidade sobre temas contemporâneos. A publicação é vinculada ao Programa de Pós-Graduação do Instituto de Estudos Sociais e Políticos da UERJ (IESP/UERJ). É permitida a reprodução deste boletim e dos dados nele contidos, desde que citada a fonte. Reproduções para fins comerciais são proibidas. Corpo Editorial Conselho Editorial Fernanda Cristina Nanci Izidro Gonçalves Leticia Pinheiro Maria Regina Soares de Lima Editor Executivo Leandro Wolpert dos Santos Editor Adjunto Kayo Moura da Silva Editoria de Redação Amanda Silvestre da Silva André Pimentel Ferreira Leão Beatriz Pontes Edgar Andrés Londoño Niño Eduardo Morrot Coelho Madureira Ghaio Nicodemos Juliana de Sant’Anna Cunha Juliana Pinto Lemos da Silva Kayo Moura Leandro Wolpert dos Santos Leonardo Albarello Weber Luã Braga de Oliveira Marcelly Firmino Thaís Jesinski Batista Instituto de Estudos Sociais e Políticos Univesidade do Estado do Rio de Janeiro Núcleo de Estudos Atores e Agendas de Política Externa Rua da Matriz, 82 - Botafogo CEP: 22260-100 neaape.com.br Rio de Janeiro – RJ (21) 2266-8300 SUMÁRIO 4 EDITORIAL A Diplomacia das Vacinas e a Necrodiplomacia Fernanda Nanci Gonçalves Leandro Wolpert dos Santos Leticia Pinheiro 6 A Índia e a Diplomacia da Vacina: busca por influência regional e status global Erik H.
    [Show full text]
  • COVID-19: Make It the Last Pandemic
    COVID-19: Make it the Last Pandemic Disclaimer: The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Independent Panel for Pandemic Preparedness and Response concerning the legal status of any country, territory, city of area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Report Design: Michelle Hopgood, Toronto, Canada Icon Illustrator: Janet McLeod Wortel Maps: Taylor Blake COVID-19: Make it the Last Pandemic by The Independent Panel for Pandemic Preparedness & Response 2 of 86 Contents Preface 4 Abbreviations 6 1. Introduction 8 2. The devastating reality of the COVID-19 pandemic 10 3. The Panel’s call for immediate actions to stop the COVID-19 pandemic 12 4. What happened, what we’ve learned and what needs to change 15 4.1 Before the pandemic — the failure to take preparation seriously 15 4.2 A virus moving faster than the surveillance and alert system 21 4.2.1 The first reported cases 22 4.2.2 The declaration of a public health emergency of international concern 24 4.2.3 Two worlds at different speeds 26 4.3 Early responses lacked urgency and effectiveness 28 4.3.1 Successful countries were proactive, unsuccessful ones denied and delayed 31 4.3.2 The crisis in supplies 33 4.3.3 Lessons to be learnt from the early response 36 4.4 The failure to sustain the response in the face of the crisis 38 4.4.1 National health systems under enormous stress 38 4.4.2 Jobs at risk 38 4.4.3 Vaccine nationalism 41 5.
    [Show full text]
  • Module 3 - How Can We Trust the Vaccines?
    Module 3 - How can we trust the vaccines? [00:00:10] Hello, welcome back to our MOOC, Covering the COVID-19 Vaccines: What Journalists Need to Know. I'm Maryn McKenna, your chief instructor and this is our third module. [00:00:24] In the first episode and materials, we talked about how we got to where we are now, the history of the pandemic and the achievement of vaccines that may stop it. In the second, we talked about the logistical and political barriers to getting vaccines distributed across the globe. [00:00:43] In this one, we're going to talk about what would prevent someone from taking the vaccine once it arrives where they are, the enormous amount of misinformation and disinformation swirling around the vaccines. This is a concern because the science is very clear, misinformation and disinformation aren't just noise, they have an effect. [00:01:08] When people read or watch or listen to false information about COVID, they are less likely to act to protect themselves, less likely to wear a mask, follow social distancing or accept the vaccine. Before we go any further into this, let's define our terms. In the definition of the researchers whose work we're recommending in this module, misinformation is most likely to be something passed along innocently, say your auntie pasting a rumor about the COVID vaccine into your family group chat. [00:01:47] The content is false, but the intent is not malicious. Disinformation is malicious - - it is weaponized misinformation created in order to have a destructive effect.
    [Show full text]
  • Vaccine Diplomacy in India’S Neighbourhood Sohini Bose Editor
    145 SPECIAL . no The Dynamics of Vaccine Diplomacy in India’s Neighbourhood Sohini Bose Editor JUNE 2021 © 2021 Observer Research Foundation. All rights reserved. No part of this publication may be reproduced, copied, archived, retained or transmitted through print, speech or electronic media without prior written approval from ORF. Introduction n early 2021, India—driven by its ‘Neighbourhood First’ policy1 and in its understanding of its role as the ‘net security provider’ of the region—2 began providing This special report examines the dynamics of COVID-19 vaccines on a priority basis vaccine diplomacy in India’s neighbourhood. In Ito its immediate neighbours.a Between January five sections, the report explores the state of the and April, India either sold or granted a total of countries’ vaccine rollout, the gaps in supply that 19,542,000 vaccine doses to countries in the region,3 either China or Russia is bridging as India halted until it stopped further exports in late April when it vaccine supply, and the implications of such efforts became clear that the second wave of the pandemic on the bigger geostrategic picture across India’s was going to be far more severe than the first one near-neighbourhood. in 2020. Today, at the time of writing this report, a significant volume of vaccines purchased from In her essay on Bangladesh—often referred to India by some of these near-neighbours remains as India’s “closest alliance” in the neighbourhood,5 undelivered. Moreover, the promise of the Quad Sohini Bose highlights the diplomatic challenges countriesb “to expand and accelerate production it faces in balancing the strategic underpinnings [of vaccines] in India” for the Indo-Pacific4 remains of the vaccine assistance it receives.
    [Show full text]
  • The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia's Vaccine
    Article The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia’s Vaccine Rollout Slower than That of Other Nations? Elza Mikule 1,*,† , Tuuli Reissaar 1,† , Jennifer Villers 1,† , Alain Simplice Takoupo Penka 1,† , Alexander Temerev 2 and Liudmila Rozanova 2 1 Global Studies Institute, University of Geneva, 1205 Geneva, Switzerland; [email protected] (T.R.); [email protected] (J.V.); [email protected] (A.S.T.P.) 2 Institute of Global Health, University of Geneva, 1202 Geneva, Switzerland; [email protected] (A.T.); [email protected] (L.R.) * Correspondence: [email protected] † These authors contributed equally. Abstract: The emergence of the SARS-CoV-2 pandemic in the beginning of 2020 led to the deployment of enormous amounts of resources by different countries for vaccine development, and the Russian Federation was the first country in the world to approve a COVID-19 vaccine on 11 August 2020. In our research we sought to crystallize why the rollout of Sputnik V has been relatively slow considering that it was the first COVID-19 vaccine approved in the world. We looked at production capacity, at the number of vaccine doses domestically administered and internationally exported, and at vaccine hesitancy levels. By 6 May 2021, more first doses of Sputnik V had been administered Citation: Mikule, E.; Reissaar, T.; abroad than domestically, suggesting that limited production capacity was unlikely to be the main Villers, J.; Takoupo Penka, A.S.; reason behind the slow rollout. What remains unclear, however, is why Russia prioritized vaccine Temerev, A.; Rozanova, L.
    [Show full text]
  • Hudson Institute
    POLICY MEMO A Strategic US Approach to India’s COVID-19 Crisis AMB. HUSAIN HAQQANI Director, South and Central Asia, Hudson Institute APARNA PANDE Director, Initiative on the Future of India and South Asia, Hudson Institute June 2021 Introduction However, the resurgence of COVID-19 has jolted India at The recent surge of COVID-19 in South Asia challenges India’s a time when democratic countries, including the United traditional ability to aid its smaller neighbors, a change that States, view India as critical to balancing China’s deepening could, in turn, affect India’s influence in its competition with influence cross Asia. South Asia, a region holding 23 percent China. Unless India can recover from this surge with the help of the world’s population, now accounts for over 11 percent of allies like the United States, the pandemic could impact the of global COVID-19 cases and 6 percent of COVID-related Indo-Pacific’s geopolitical balance. deaths. The world’s largest democracy and second-most populous country, India alone currently accounts for over 84 In the past, India has often acted as a first responder across percent of South Asia’s cases and deaths. South Asia, helping other countries recover from natural disasters, and it initially occupied this role during the first For most of 2020, it appeared that India, thanks partly to a months of the coronavirus pandemic, when it helped several lockdown, had managed to avert a huge health crisis. During South Asian and Indian Ocean region countries cope with the this time, India supported its immediate South Asian neighbors effects of the disease.
    [Show full text]
  • Accesso Ai Vaccini: Diritto Internazionale Ed Europeo Indice
    ISSN 2384-9169 NUMERO SPECIALE www.eurojus.it Accesso ai vaccini: diritto internazionale ed europeo Indice 1. GIANLUCA CONTALDI E ANDREA CALIGIURI, Introduzione...........................................1 2. GIACOMO DI FEDERICO, La strategia dell’Unione europea per i vaccini tra principio di attribuzione e leale collaborazione.............................................................................8 3. VINCENZO SALVATORE, La valutazione dei vaccini nell’Unione europea...................15 4. CARLO CURTI GIALDINO, Diplomazia dei vaccini e politica estera al tempo della pandemia da COVID-19...............................................................................................21 5. JULIANA RODRÍGUEZ RODRIGO, A few thoughts on the Advance Purchase Agreement of COVID-19 vaccine between the European Commission and AstraZeneca..............31 6. PIA ACCONCI, L’effettività delle azioni internazionali per l’immunizzazione planetaria antiCOVID-19 tra interessi collettivi e unilaterali.......................................................51 7. FEDERICA PASSARINI, Il ruolo degli Stati e dell’OMS nel contrasto alle malattie epidemiche e il problema dell’iniqua distribuzione dei vaccini...................................69 Introduzione DI GIANLUCA CONTALDI* E ANDREA CALIGIURI** Sommario: 1. Un’analisi del problema dell’accesso ai vaccini nella prospettiva del diritto internazionale ed europeo. – 2. Alcune osservazioni preliminari in merito alle strategie nazionali sui vaccini anti-Covid nell’ottica della tutela del diritto umano alla salute.
    [Show full text]
  • A Comparative Analysis of the EU and ASEAN Bruno Jetin
    How will the COVID-19 pandemic affect the regions? A comparative analysis of the EU and ASEAN Bruno Jetin To cite this version: Bruno Jetin. How will the COVID-19 pandemic affect the regions? A comparative analysis of theEU and ASEAN. 2021. halshs-03171573 HAL Id: halshs-03171573 https://halshs.archives-ouvertes.fr/halshs-03171573 Preprint submitted on 17 Mar 2021 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. How will the COVID-19 pandemic affect the regions? A comparative analysis of the EU and ASEAN Bruno Jetin Universiti Brunei Darussalam Working Paper No.63 Institute of Asian Studies, Universiti Brunei Darussalam Gadong 2021 Editorial Board, Working Paper Series Professor Lian Kwen Fee, Institute of Asian Studies, Universiti Brunei Darussalam. Associate Professor Paul J. Carnegie, Institute of Asian Studies, Universiti Brunei Darussalam. Authors Bruno Jetin is Associate Professor and Director of the Institute of Asian Studies, Universiti Brunei Darussalam. Prior to joining UBD, he was researcher at the Institute for Research on Contemporary Southeast Asia (IRASEC, CNRS-MAEE, Bangkok) and Associate Professor at the University Sorbonne Paris Nord where he was Deputy Director and then Acting Director (2010-2012) of the Research Center in Economics.
    [Show full text]
  • Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-Science Peter Hotez MD Phd @Peterhotez
    Preventing the next Pandemic: Vaccine Diplomacy in a time of Anti-Science Peter Hotez MD PhD Texas Children’s Hospital Endowed Chair in Tropical Pediatrics Dean, National School of Tropical Medicine at Baylor College of Medicine University Professor, Baylor University Hagler Institute of Advanced Studies, Texas A&M University @PeterHotez 1 Under 5 Child Deaths 2000-2017 GBD 2017 Sebastiao Salgado 2000 2017 ‐ Measles 478,727 ‐ Measles 83,438 (-83%) ‐ Pertussis 138,048 ‐ Pertussis 86,091 (-38%) ‐ Tetanus 105,333 ‐ Tetanus 18,623 (-82%) ‐ H. flu 86,104 ‐ H.flu 36,185 (-58%) ‐ Diphtheria 10,413 ‐ Diphtheria 2,914 (-72%) Page 2 xxx00.#####.ppt 5/7/2020 1:49:32 PM Incidence of Hib in USA 3 Global Elimination of Polio & Measles 4 New Global Anthropocene “Hot Zones” of Vaccine- Preventable & Neglected Tropical Diseases NTDs Where political instability combines with climate change, urbanization, deforestation, or antiscience Texas &Gulf Arabian Coast Peninsula China and Philippines Central Africa’s Latin Un-Wars America 5 War, Political Collapse, Climate Change, Urbanization • Arabian Peninsula • Venezuela 6 War, Political Collapse, Climate Change, Urbanization • Africa Un-Wars • Texas + Gulf Coast 7 SHIFTING POVERTY: “Blue Marble Health” • Neglected diseases of the poor living amidst wealth • A new framework for global science policy and the poverty-related diseases 8 COVID19 and the G20 Nations • 2-3 million cases • United States • Spain • Italy • France • Germany • UK • China • Turkey 9 Tissue Expression of ACE2: Heart, Lung, Adipose, Gastrointestinal
    [Show full text]
  • India's Vaccine Diplomacy: Combating Pandemic, the India Way Manish
    India’s Vaccine Diplomacy: Combating Pandemic, the India Way Manish Chand It was a shining moment of pride for over 1.3 billion people of India, and an emotional moment for Prime Minister Narendra Modi when he launched the world’s largest vaccination drive on January 16. Broadcast live on the national television, the much-awaited vaccine roll-out has ignited optimism anew about a healthier and happier future. The vaccination drive has been tracked closely in the world as the “Made-in-India” vaccines promise deliverance from the lethal curse of the coronavirus pandemic that has killed millions around the world. ”It takes years to prepare vaccines. But in the shortest span of time, we ​ have not only one but two India-made vaccines,” PM Modi said while showering praise on Indian scientists who worked tirelessly to make what seemed impossible possible. The sheer scale of India’s vaccination drive is staggering: by the second phase, India hopes to inoculate over 300 million people, which exceeds the population of Britain, France, Germany and Italy combined. “There are only three countries in the world with more than 30 crore population: India, the US and China. Hence, this is going to be the biggest vaccination drive,” PM Modi said. India in V5 Club The indigenous development and manufacturing of the twin vaccines -- Covishield (the local name for the Oxford-AstraZeneca vaccine developed in the UK in collaboration with Serum Institute of India) and Covaxin, locally made by pharma company Bharat Biotech – is a high point in India’s technology journey and another feather in its reputation as the world’s pharma powerhouse.
    [Show full text]
  • Astrazeneca Vaccine Disinformation on Twitter
    medRxiv preprint doi: https://doi.org/10.1101/2021.04.08.21255107; this version posted April 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . # AstraZeneca vaccine disinformation on Twitter Dariusz Jemielniak Kozminski University, [email protected] Yaroslav Krempovych Kozminski University, [email protected] Abstract We analyzed 50,080 tweets about # AstraZeneca in English from 2021. We found that the news most common in the frequently retweeted tweets abound in negative information, and in many cases come from media sources well-known for disinfor- mation. Also, we found that RT, a Russian state-sponsored news website, as well as Al Arabiya, a Saudi-owned news website, are frequently retweeted with infor- mation about the vaccine. Our analysis identified large coordination networks involved in political astroturfing and vaccine diplomacy in South Asia but also vaccine advocacy networks associated with European Commission employees. Our results show that Twitter discourse about # AstraZeneca is filled with disinfor- mation and bad press, and may be distributed not only organically by anti-vaxxer activists, but also systematically by professional sources. NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2021.04.08.21255107; this version posted April 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]